NO941683L - - Google Patents

Info

Publication number
NO941683L
NO941683L NO941683A NO941683A NO941683L NO 941683 L NO941683 L NO 941683L NO 941683 A NO941683 A NO 941683A NO 941683 A NO941683 A NO 941683A NO 941683 L NO941683 L NO 941683L
Authority
NO
Norway
Prior art keywords
alpha
azacholesta
seco
trien
alkenylene
Prior art date
Application number
NO941683A
Other languages
English (en)
Norwegian (no)
Other versions
NO305315B1 (no
NO941683D0 (no
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919123712A external-priority patent/GB9123712D0/en
Priority claimed from GB929209658A external-priority patent/GB9209658D0/en
Application filed filed Critical
Publication of NO941683D0 publication Critical patent/NO941683D0/no
Publication of NO941683L publication Critical patent/NO941683L/no
Publication of NO305315B1 publication Critical patent/NO305315B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
NO941683A 1991-11-07 1994-05-06 Vitamin D-amid-derivater NO305315B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919123712A GB9123712D0 (en) 1991-11-07 1991-11-07 Chemical compounds
GB929209658A GB9209658D0 (en) 1992-05-05 1992-05-05 Chemical compounds
PCT/EP1992/002577 WO1993009093A1 (fr) 1991-11-07 1992-11-06 Derives amines de vitamine d

Publications (3)

Publication Number Publication Date
NO941683D0 NO941683D0 (no) 1994-05-06
NO941683L true NO941683L (fr) 1994-06-27
NO305315B1 NO305315B1 (no) 1999-05-10

Family

ID=26299825

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941683A NO305315B1 (no) 1991-11-07 1994-05-06 Vitamin D-amid-derivater

Country Status (20)

Country Link
US (2) US5494905A (fr)
EP (1) EP0614455B1 (fr)
JP (1) JP3282811B2 (fr)
KR (1) KR100271461B1 (fr)
AT (1) ATE134366T1 (fr)
AU (1) AU664213B2 (fr)
CA (1) CA2121678C (fr)
CZ (1) CZ288031B6 (fr)
DE (1) DE69208478T2 (fr)
DK (1) DK0614455T3 (fr)
ES (1) ES2083771T3 (fr)
FI (1) FI106119B (fr)
GR (1) GR3019601T3 (fr)
HU (1) HU221008B1 (fr)
NO (1) NO305315B1 (fr)
NZ (1) NZ245041A (fr)
PL (1) PL171580B1 (fr)
RU (1) RU2139276C1 (fr)
SK (1) SK281302B6 (fr)
WO (1) WO1993009093A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU221008B1 (hu) * 1991-11-07 2002-07-29 Research Institute For Medicine And Chemistry D-vitamin-származékok és azokat tartalmazó gyógyászati készítmények
IL107185A (en) * 1992-10-06 1998-02-22 Schering Ag Vitamin d, 25-carboxylic acid derivatives and pharmaceutical compositions containing the same
WO2004076688A1 (fr) * 1993-02-12 2004-09-10 Etsuro Ogata Methode de surveillance d'une nephropathie asymptomatique
GB9309422D0 (en) * 1993-05-07 1993-06-23 Res Inst Medicine Chem Chemical compounds
GB9325415D0 (en) * 1993-12-13 1994-02-16 Res Inst Medicine Chem Chemical compounds
GB9405715D0 (en) * 1994-03-23 1994-05-11 Res Inst Medicine Chem Chemical compounds
US5661141A (en) * 1995-03-27 1997-08-26 Petrow; Vladimir 19-oxygenated steroids as therapeutic agents
US5678570A (en) * 1995-04-14 1997-10-21 The University Of North Carolina At Chapel Hill Method of treating cardiac arrest
US5696103A (en) * 1995-11-17 1997-12-09 Syntex (U.S.A.) Inc. Method for treating osteoporosis
DE19619036A1 (de) * 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
US6043385A (en) * 1997-12-16 2000-03-28 Hoffman-La Roche Inc. Vitamin D derivatives
GB9804861D0 (en) 1998-03-06 1998-04-29 Res Inst Medicine Chem Chemical compounds
AU758792B2 (en) * 1998-10-23 2003-03-27 Teijin Limited Vitamin D3 derivatives and remedies for inflammatory respiratory diseases containing the same
DE19935771A1 (de) * 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
CA2385755C (fr) 1999-09-29 2007-02-06 Colotech A/S Prevention du cancer colorectal
US6703380B2 (en) 1999-09-29 2004-03-09 Colotech A/S Prevention of cancer
WO2001030751A2 (fr) * 1999-10-25 2001-05-03 Strakan Limited Utilisations de composes de 1,25-dihydroxy-5,6-trans vitamine d et de leurs derives
IL153395A0 (en) * 2000-06-15 2003-07-06 Chugai Pharmaceutical Co Ltd Vitamin d derivatives
CA2586679A1 (fr) 2004-11-12 2006-05-18 Bioxell Spa Emploi combine de derives de vitamine d et d'agents antiproliferants pour le traitement de cancers de la vessie
US20100016435A1 (en) * 2006-05-16 2010-01-21 Mcgill University Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties
WO2009117831A1 (fr) * 2008-03-27 2009-10-01 The Royal Institution For The Advancement Of Learning/Mcgill University Molécules hybrides associant aux propriétés d'agonisme du récepteur de la vitamine d, des propriétés d'inhibition de l'histone désacétylase
US8987235B2 (en) 2011-05-17 2015-03-24 Wisconsin Alumni Research Foundation N-cyclopropyl-(20R)-2-methylene-19,26,27-trinor-25-aza-vitamin D analogs and their uses
EP4215519A4 (fr) * 2020-09-15 2024-03-06 Teijin Pharma Limited Dérivé de vitamine d ayant une amine cyclique dans la chaîne latérale

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217288A (en) * 1977-03-24 1980-08-12 Wisconsin Alumni Research Foundation Anti-vitamin D compounds
FR2426044A2 (fr) * 1978-05-19 1979-12-14 Wisconsin Research Foundation Derives de la vitamine d3 ayant une activite anti-vitamine d
ATE74269T1 (de) * 1987-07-29 1992-04-15 Takeda Chemical Industries Ltd Zellproliferationsinhibitor.
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
HU221008B1 (hu) * 1991-11-07 2002-07-29 Research Institute For Medicine And Chemistry D-vitamin-származékok és azokat tartalmazó gyógyászati készítmények

Also Published As

Publication number Publication date
PL171580B1 (pl) 1997-05-30
US5686435A (en) 1997-11-11
HU221008B1 (hu) 2002-07-29
WO1993009093A1 (fr) 1993-05-13
EP0614455B1 (fr) 1996-02-21
ATE134366T1 (de) 1996-03-15
HUT67140A (en) 1995-02-28
SK281302B6 (sk) 2001-02-12
ES2083771T3 (es) 1996-04-16
AU664213B2 (en) 1995-11-09
FI942114A0 (fi) 1994-05-06
NZ245041A (en) 1995-03-28
DK0614455T3 (da) 1996-03-18
CZ111294A3 (en) 1995-03-15
NO305315B1 (no) 1999-05-10
AU2901492A (en) 1993-06-07
RU2139276C1 (ru) 1999-10-10
GR3019601T3 (en) 1996-07-31
EP0614455A1 (fr) 1994-09-14
CA2121678C (fr) 2005-03-15
US5494905A (en) 1996-02-27
SK52294A3 (en) 1994-11-09
FI942114L (fi) 1994-05-06
CA2121678A1 (fr) 1993-05-13
DE69208478D1 (de) 1996-03-28
HU9401372D0 (en) 1994-08-29
JPH07502499A (ja) 1995-03-16
CZ288031B6 (cs) 2001-04-11
FI106119B (fi) 2000-11-30
DE69208478T2 (de) 1996-09-05
NO941683D0 (no) 1994-05-06
KR100271461B1 (ko) 2000-11-15
JP3282811B2 (ja) 2002-05-20

Similar Documents

Publication Publication Date Title
NO941683L (fr)
IL104489A0 (en) Carbamates and crop protection agents containing them
IL109595A (en) Vitamin d amide derivatives
ATE48010T1 (de) Schlagzaeh modifiziertes polyoxymethylen und daraus hergestellte formkoerper.
IL90336A (en) N-heterocyclic-4- guanylalkylbenzamide protease inhibitors
MX9709398A (es) N-aril-1,2,4-triazolin-5-onas.
PH24074A (en) Antiarrhythmic agents
EP0379483A4 (en) 1,2,3,4,10,14b-hexahydrodibenzo c,f¨pyrazino- 1,2-a¨azepino derivatives and 10-aza, 10-oxa and 10-thia analogues
AP8800109A0 (en) "Heterocyclic insecticides".
EP0532629A4 (fr)
EP0269041A3 (en) Fungicidal cyclohexylamines
YU186689A (en) N-sulphenilated and n-acylated pyrazolins
ES8507562A1 (es) Procedimiento para la obtencion de un derivado de organofosfato
AP9300580A0 (en) Oxa- and thiadiazole derivatives.
IL64053A0 (en) Hydroxamic acid esters,their preparation and their use for combating pests
ES8506297A1 (es) Procedimiento para la obtencion de 1, 3, 5-tiadiazin-2-tioxo-4-onas 3, 6-disustituidas
ES8300704A1 (es) Un procedimiento para la preparacion del n-oxido del 4 hetoxi-n-(2-(-(imetil-2-piperidil) etil) fenil)benzamida.
ATE41849T1 (de) Herbizide.